## **Core Concept**
The question requires selecting a muscle relaxant suitable for a patient with elevated serum bilirubin (indicative of liver dysfunction) and elevated serum creatinine (indicative of kidney dysfunction). The ideal muscle relaxant in this scenario should have minimal hepatic and renal metabolism or excretion.

## **Why the Correct Answer is Right**
Atracurium is the correct answer because it undergoes **Hoffmann elimination**, a non-enzymatic degradation process that occurs in plasma at physiological pH and temperature. This unique elimination pathway makes atracurium an ideal choice for patients with both liver and kidney dysfunction, as its metabolism and excretion are independent of hepatic and renal function.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Succinylcholine is metabolized by plasma cholinesterase and excreted by the kidneys. Its use in renal failure might not be ideal due to potential accumulation of succinylcholine and its metabolite, and it is not specifically indicated for liver dysfunction.
* **Option B:** Vecuronium primarily undergoes hepatic metabolism and biliary excretion, with some metabolites excreted in the urine. Its use in significant liver dysfunction may not be ideal.
* **Option D:** Pancuronium is primarily excreted by the kidneys, making it less suitable for patients with significant renal impairment.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **atracurium** and **cisatracurium** (a related compound with similar pharmacokinetics) are often considered safe choices for patients with combined liver and kidney dysfunction because of their unique elimination pathways.

## **Correct Answer:** . Atracurium.